Kinase drug discovery 20 years after imatinib: progress and future directions

P Cohen, D Cross, PA Jänne - Nature reviews drug discovery, 2021 - nature.com
Protein kinases regulate nearly all aspects of cell life, and alterations in their expression, or
mutations in their genes, cause cancer and other diseases. Here, we review the remarkable …

Amide bond bioisosteres: Strategies, synthesis, and successes

S Kumari, AV Carmona, AK Tiwari… - Journal of medicinal …, 2020 - ACS Publications
The amide functional group plays a key role in the composition of biomolecules, including
many clinically approved drugs. Bioisosterism is widely employed in the rational …

[HTML][HTML] Vascular endothelial growth factor receptor (VEGFR-2)/KDR inhibitors: medicinal chemistry perspective

SJ Modi, VM Kulkarni - Medicine in Drug Discovery, 2019 - Elsevier
New blood vessels formation from the existing vasculature is called angiogenesis. It is an
essential physiological process for the growth of cells, tissue repair, wound healing, and …

Potential therapeutic options for COVID-19: current status, challenges, and future perspectives

C Sarkar, M Mondal, M Torequl Islam… - Frontiers in …, 2020 - frontiersin.org
The COVID-19 pandemic represents an unprecedented challenge for the researchers to
offer safe, tolerable, and effective treatment strategies for its causative agent known as …

Leukemia: an overview for primary care

AS Davis, AJ Viera, MD Mead - American family physician, 2014 - aafp.org
Leukemia is a clonal proliferation of hematopoietic stem cells in the bone marrow. The four
broad subtypes most likely to be encountered by primary care physicians are acute …

BreaKmer: detection of structural variation in targeted massively parallel sequencing data using kmers

RP Abo, M Ducar, EP Garcia, AR Thorner… - Nucleic acids …, 2015 - academic.oup.com
Genomic structural variation (SV), a common hallmark of cancer, has important predictive
and therapeutic implications. However, accurately detecting SV using high-throughput …

The value of drug repositioning in the current pharmaceutical market.

EL Tobinick - Drug news & perspectives, 2009 - europepmc.org
Drug repositioning is the process of developing new indications for existing drugs or
biologics. Increasing interest in drug repositioning has occurred due to sustained high …

Substrates, inducers, inhibitors and structure-activity relationships of human Cytochrome P450 2C9 and implications in drug development

SF Zhou, ZW Zhou, LP Yang… - Current medicinal …, 2009 - ingentaconnect.com
Cytochrome P450 2C9 (CYP2C9) is one of the most abundant CYP enzymes in the human
liver. CYP2C9 metabolizes more than 100 therapeutic drugs, including tolbutamide …

Can bottom-up synthetic biology generate advanced drug-delivery systems?

F Lussier, O Staufer, I Platzman, JP Spatz - Trends in Biotechnology, 2021 - cell.com
Creating a magic bullet that can selectively kill cancer cells while sparing nearby healthy
cells remains one of the most ambitious objectives in pharmacology. Nanomedicine, which …

Ir-catalyzed ligand-free directed C–H borylation of arenes and pharmaceuticals: detailed mechanistic understanding

MM Mahamudul Hassan, B Mondal… - The Journal of …, 2022 - ACS Publications
An efficient method for Ir-catalyzed ligand free ortho borylation of arenes (such as, 2-
phenoxypyridines, 2-anilinopyridines, benzylamines, benzylpiperazines …